Free Trial
NASDAQ:MEDP

Medpace Q2 2025 Earnings Report

Medpace logo
$306.80 -4.34 (-1.39%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$306.79 -0.01 (0.00%)
As of 06/26/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medpace EPS Results

Actual EPS
N/A
Consensus EPS
$3.01
Beat/Miss
N/A
One Year Ago EPS
N/A

Medpace Revenue Results

Actual Revenue
N/A
Expected Revenue
$537.70 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Medpace Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Tuesday, July 22, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

Medpace Earnings Headlines

Medpace (NASDAQ:MEDP) Coverage Initiated at Barclays
A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
MEDP - Medpace Holdings Inc Trailing Returns | Morningstar
See More Medpace Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medpace? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medpace and other key companies, straight to your email.

About Medpace

Medpace (NASDAQ:MEDP) engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

View Medpace Profile

More Earnings Resources from MarketBeat